Primacy and recency effects in verbal memory are differentially associated with post-mortem frontal cortex p-tau 217 and 202 levels in a mixed sample of community-dwelling older adults

References

• Aguillonm, D., Langella, S., Chen, Y., Sanchez, J. S., Su, Y., Vila-Castelar, C., Vasquez, D., Zetterberg, H., Hansson, O., Dage, J. L., Janelidze, S., Chen, K., Fox-Fuller, J. T., Auden, P., Martinez, J. E., Garcia, G., Baena, A., Guzman, C., Johnson, K. A., Quiroz, Y. T. (2022). Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia, . Advance online publication https://doi.org/10.1002/alz.12906
   Google Scholar
• Arvanitakis, Z., Capuano, A. W., Leurgans, S. E., Buchman, A. S., Bennett, D. A., & Schneider, J. A. (2017). The relationship of cerebral vessel pathology to brain microinfarcts. Brain Pathology, 27(1), 77–85. https://doi.org/10.1111/bpa.12365
   PubMed Web of Science ®Google Scholar
• Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011). Microinfarct pathology, dementia, and cognitive systems. Stroke, 42(3), 722–727. https://doi.org/10.1161/STROKEAHA.110.595082
   PubMed Web of Science ®Google Scholar
• Ashton, N. J., Janelidze, S., Mattsson-Carlgren, N., Binette, A. P., Strandberg, O., Brum, W. S., Karikari, T. K., González-Ortiz, F., Di Molfetta, G., Meda, F. J., Jonaitis, E. M., Koscik, R. L., Cody, K., Betthauser, T. J., Li, Y., Vanmechelen, E., Palmqvist, S., Stomrud, E., Bateman, R. J., Hansson, O. (2022). Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring. Nature Medicine, 28(12), 2555–2562. https://doi.org/10.1038/s41591-022-02074-w
   PubMed Web of Science ®Google Scholar
• Atkinson, R. C., & Shiffrin, R. M. (1968). Human memory: A proposed system and its control processes. Psychology of Learning and Motivation, 2, 89–195. https://doi.org/10.1016/S0079-7421(08)60422-3
   Google Scholar
• Barthélemy, N. R., Bateman, R. J., Hirtz, C., Marin, P., Becher, F., Sato, C., Gabelle, A., & Lehmann, S. (2020). Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification. Alzheimer’s Research & Therapy, 12(1), 26. https://doi.org/10.1186/s13195-020-00596-4
   PubMed Web of Science ®Google Scholar
• Barthélemy, N. R., Li, Y., Joseph-Mathurin, N., Gordon, B. A., Hassenstab, J., Benzinger, T. L. S., Buckles, V., Fagan, A. M., Perrin, R. J., Goate, A. M., Morris, J. C., Karch, C. M., Xiong, C., Allegri, R., Mendez, P. C., Berman, S. B., Ikeuchi, T., Mori, H., Shimada, H., McDade, E. 2020. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease. Nature Medicine, 26(3) 26: 3 398–407. https://doi.org/10.1038/s41591-020-0781-z
   Google Scholar
• Bayley, P. J., Salmon, D. P., Bondi, M. W., Bui, B. K., Olichney, J., Delis, D. C., Thomas, R. G., & Thal, L. J. (2000). Comparison of the serial position effect in very mild Alzheimer’s disease, mild Alzheimer’s disease, and amnesia associated with electroconvulsive therapy. Journal of the International Neuropsychological Society, 6(3), 290–298. https://doi.org/10.1017/S1355617700633040
   PubMed Web of Science ®Google Scholar
• Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018). Religious orders study and rush memory and aging project. Journal of Alzheimer’s Disease, 64, S161–S189. https://doi.org/10.3233/JAD-179939
   PubMed Web of Science ®Google Scholar
• Bennett, D. A., Schneider, J. A., Aggarwal, N. T., Arvanitakis, Z., Shah, R. C., Kelly, J. F., Fox, J. H., Cochran, E. J., Arends, D., Treinkman, A. D., & Wilson, R. S. (2006). Decision rules guiding the clinical diagnosis of Alzheimer’s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology, 27(3), 169–176. https://doi.org/10.1159/000096129
   PubMed Web of Science ®Google Scholar
• Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006). Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology, 66(12), 1837–1844. https://doi.org/10.1212/01.wnl.0000219668.47116.e6
   PubMed Web of Science ®Google Scholar
• Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002). Natural history of mild cognitive impairment in older persons. Neurology, 59(2), 198–205. https://doi.org/10.1212/wnl.59.2.198
   PubMed Web of Science ®Google Scholar
• Blennow, K., & Zetterberg, H. (2018). Biomarkers for Alzheimer’s disease: Current status and prospects for the future. Journal of Internal Medicine, 284(6), 643–663. https://doi.org/10.1111/joim.12816
   PubMed Web of Science ®Google Scholar
• Braak, H., & Del Tredici, K. (2015). The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain, 138(10), 2814–2833. https://doi.org/10.1093/brain/awv236
   PubMedGoogle Scholar
• Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., Cairns, N. J., Holtzman, D. M., Fagan, A. M., Morris, J. C., Benzinger, T. L. S., & Ances, B. M. (2016). Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease. Science Translational Medicine, 8(338), 338ra66. https://doi.org/10.1126/scitranslmed.aaf2362
   PubMed Web of Science ®Google Scholar
• Bruno, D., Gleason, C. E., Koscik, R. L., Pomara, N., Zetterberg, H., Blennow, K., & Johnson, S. C. (2019). The recency ratio is related to CSF amyloid beta 1-42 levels in MCI-AD. International Journal of Geriatric Psychiatry, 34(3), 415–419. https://doi.org/10.1002/gps.5029
   PubMed Web of Science ®Google Scholar
• Bruno, D., Grothe, M. J., Nierenberg, J., Zetterberg, H., Blennow, K., Teipel, S. J., & Pomara, N. (2015). A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Neuropsychologia, 69, 1–8. https://doi.org/10.1016/j.neuropsychologia.2015.01.025
   PubMed Web of Science ®Google Scholar
• Bruno, D., Jauregi Zinkunegi, A., Kollmorgen, G., Suridjan, I., Wild, N., Carlsson, C., Bendlin, B., Okonkwo, O., Chin, N., Hermann, B. P., Asthana, S., Zetterberg, H., Blennow, K., Langhough, R., Johnson, S. C., & Mueller, K. D. (2023). The recency ratio assessed by story recall is associated with cerebrospinal fluid levels of neurodegeneration biomarkers. Cortex, 159, 167–174. https://doi.org/10.1016/j.cortex.2022.12.004
   PubMed Web of Science ®Google Scholar
• Bruno, D., Koscik, R. L., Woodard, J. L., Pomara, N., & Johnson, S. C. (2018). The recency ratio as predictor of early MCI. International Psychogeriatrics, 30(12), 1883–1888. https://doi.org/10.1017/S1041610218000467
   PubMed Web of Science ®Google Scholar
• Bruno, D., Mueller, K. D., Betthauser, T., Chin, N., Engelman, C. D., Christian, B., Koscik, R. L., & Johnson, S. C. (2021). Serial position effects in the logical memory test: Loss of primacy predicts amyloid positivity. Journal of Neuropsychology, 15(3), 448–461. https://doi.org/10.1111/jnp.12235
   PubMed Web of Science ®Google Scholar
• Bruno, D., Reichert, C., & Pomara, N. (2016). The recency ratio as an index of cognitive performance and decline in elderly individuals. Journal of Clinical and Experimental Neuropsychology, 38(9), 967–973. https://doi.org/10.1080/13803395.2016.1179721
   PubMed Web of Science ®Google Scholar
• Buchman, A. S., Leurgans, S. E., Nag, S., Bennett, D. A., & Schneider, J. A. (2011). Cerebrovascular disease pathology and Parkinsonian signs in old age. Stroke, 42, 3183–3189. https://doi.org/10.1161/STROKEAHA.111.623462
   PubMed Web of Science ®Google Scholar
• Calcetas, A. T., Thomas, K. R., Edmonds, E. C., Holmqvist, S. L., Edwards, L., Bordyug, M., Delano-Wood, L., Brickman, A. M., Bondi, M. W., & Bangen, K. J., The Alzheimer’s Disease Neuroimaging Initiative. (2022). Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment. Neurobiology of Aging, 118 1–8. https://doi.org/10.1016/j.neurobiolaging.2022.06.002
   PubMed Web of Science ®Google Scholar
• Cerami, C., Dubois, B., Boccardi, M., Monsch, A. U., Demonet, J. F., & Cappa, S. F. 2017. Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework. Neurobiology of Aging, 52 Geneva Task Force for the Roadmap of Alzheimer’s Biomarkers, 153–166. https://doi.org/10.1016/j.neurobiolaging.2016.03.034
   PubMed Web of Science ®Google Scholar
• Cunha, C., Guerreiro, M., de Mendonça, A., Oliveira, P. E., & Santana, I. (2012). Serial position effects in Alzheimer’s disease, mild cognitive impairment, and normal aging: Predictive value for conversion to dementia. Journal of Clinical and Experimental Neuropsychology, 34(8), 841–852. https://doi.org/10.1080/13803395.2012.689814
   PubMed Web of Science ®Google Scholar
• Fagan, A. M., Xiong, C., Jasielec, M. S., Bateman, R. J., Goate, A. M., Benzinger, T. L. S., Ghetti, B., Martins, R. N., Masters, C. L., Mayeux, R., Ringman, J. M., Rossor, M. N., Salloway, S., Schofield, P. R., Sperling, R. A., Marcus, D., Cairns, N. J., Buckles, V. D., & Ladenson, J. H. (2014). Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s disease. Science Translational Medicine, 6(226), 226ra30. Dominantly Inherited Alzheimer Network. https://doi.org/10.1126/scitranslmed.3007901
   PubMed Web of Science ®Google Scholar
• Foldi, N. S., Brickman, A. M., Schaefer, L. A., & Knutelska, M. E. (2003). Distinct serial position profiles and neuropsychological measures differentiate late life depression from normal aging and Alzheimer’s disease. Psychiatry Research, 120(1), 71–84. https://doi.org/10.1016/s0165-1781(03)00163-x
   PubMed Web of Science ®Google Scholar
• Garibotto, V., Boccardi, M., Chiti, A., & Frisoni, G. B. (2021). Molecular imaging and fluid biomarkers of Alzheimer’s disease neuropathology: An opportunity for integrated diagnostics. European Journal of Nuclear Medicine and Molecular Imaging, 48(7), 2067–2069. https://doi.org/10.1007/s00259-020-05116-y
   PubMed Web of Science ®Google Scholar
• Gicas, K. M., Honer, W. G., Leurgans, S. E., Wilson, R. S., Boyle, P. A., Schneider, J. A., & Bennett, D. A. (2022). Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. Journal of the International Neuropsychological Society, 1–11. https://doi.org/10.1017/S1355617722000595
   PubMed Web of Science ®Google Scholar
• Gicas, K. M., Honer, W. G., Wilson, R. S., Boyle, P. A., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2020). Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology, 95(24), e3303–e3312. https://doi.org/10.1212/WNL.0000000000010952
   PubMed Web of Science ®Google Scholar
• Hermann, B. P., Seidenberg, M., Wyler, A., Davies, K., Christeson, J., Moran, M., & Stroup, E. (1996). The effects of human hippocampal resection on the serial position curve. Cortex, 32(2), 323–334. https://doi.org/10.1016/s0010-9452(96)80054-2
   PubMed Web of Science ®Google Scholar
• Howieson, D. B., Mattek, N., Seeyle, A. M., Dodge, H. H., Wasserman, D., Zitzelberger, T., & Kaye, J. A. (2011). Serial position effects in mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology, 33(3), 292–299. https://doi.org/10.1080/13803395.2010.516742
   PubMed Web of Science ®Google Scholar
• Innocenti, I., Cappa, S. F., Feurra, M., Giovannelli, F., Santarnecchi, E., Bianco, G., Cincotta, M., & Rossi, S. (2013). TMS interference with primacy and recency mechanisms reveals bimodal episodic encoding in the human brain. Journal of Cognitive Neuroscience, 25(1), 109–116. https://doi.org/10.1162/jocn_a_00304
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., & Contributors. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s & Dementia, 14(4), 535–562. https://doi.org/10.1016/j.jalz.2018.02.018
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurology, 9(1), 119–128. https://doi.org/10.1016/S1474-4422(09)70299-6
   PubMed Web of Science ®Google Scholar
• Janelidze, S., Berron, D., Smith, R., Strandberg, O., Proctor, N. K., Dage, J. L., Stomrud, E., Palmqvist, S., Mattsson-Carlgren, N., & Hansson, O. (2021). Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurology, 78(2), 149–156. https://doi.org/10.1001/jamaneurol.2020.4201
   PubMed Web of Science ®Google Scholar
• Janelidze, S., Mattsson, N., Palmqvist, S., Smith, R., Beach, T. G., Serrano, G. E., Chai, X., Proctor, N. K., Eichenlaub, U., Zetterberg, H., Blennow, K., Reiman, E. M., Stomrud, E., Dage, J. L., & Hansson, O. (2020). Plasma P-tau181 in Alzheimer’s disease: Relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia. Nature Medicine, 26(3), 379–386. https://doi.org/10.1038/s41591-020-0755-1
   PubMed Web of Science ®Google Scholar
• Janelidze, S., Stomrud, E., Smith, R., Palmqvist, S., Mattsson, N., Airey, D. C., Proctor, N. K., Chai, X., Shcherbinin, S., Sims, J. R., Triana-Baltzer, G., Theunis, C., Slemmon, R., Mercken, M., Kolb, H., Dage, J. L., & Hansson, O. (2020). Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease. Nature Communications, 11, 1683. https://doi.org/10.1038/s41467-020-15436-0
   PubMed Web of Science ®Google Scholar
• Jedynak, B. M., Lang, A., Liu, B., Katz, E., Zhang, Y., Wyman, B. T., Raunig, D., Jedynak, C. P., Caffo, B., & Prince, J. L., & Alzheimer’s Disease Neuroimaging Initiative. (2012). A computational neurodegenerative disease progression score: Method and results with the Alzheimer’s disease Neuroimaging Initiative cohort. NeuroImage, 63 (3), 1478–1486. https://doi.org/10.1016/j.neuroimage.2012.07.059
   PubMed Web of Science ®Google Scholar
• La Rue, A., Hermann, B., Jones, J. E., Johnson, S., Asthana, S., & Sager, M. A. (2008). Effect of parental family history of Alzheimer’s disease on serial position profiles. Alzheimer’s & Dementia, 4(4), 285–290. https://doi.org/10.1016/j.jalz.2008.03.009
   PubMed Web of Science ®Google Scholar
• Loewenstein, D. A., Curiel, R. E., Greig, M. T., Bauer, R. M., Rosado, M., Bowers, D., Wicklund, M., Crocco, E., Pontecorvo, M., Joshi, A. D., Rodriguez, R., Barker, W. W., Hidalgo, J., & Duara, R. (2016). A novel cognitive stress test for the detection of preclinical Alzheimer disease: Discriminative properties and relation to amyloid load. The American Journal of Geriatric Psychiatry, 24(10), 804–813. https://doi.org/10.1016/j.jagp.2016.02.056
   PubMed Web of Science ®Google Scholar
• Love, S., Chalmers, K., Ince, P., Esiri, M., Attems, J., Jellinger, K., Yamada, M., McCarron, M., Minett, T., Matthews, F., Greenberg, S., Mann, D., & Kehoe, P. G. (2014). Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American Journal of Neurodegenerative Disease, 3(1), 19–32.
   PubMedGoogle Scholar
• Luna-Muñoz, J., Chávez-Macías, L., García-Sierra, F., & Mena, R. (2007). Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer’s disease. Journal of Alzheimer’s Disease, 12(4), 365–375. https://doi.org/10.3233/jad-2007-12410
   PubMed Web of Science ®Google Scholar
• Malmberg, K. J., Raaijmakers, J. G. W., & Shiffrin, R. M. (2019). 50 years of research sparked by Atkinson and Shiffrin (1968). Memory & Cognition, 47(4), 561–574. https://doi.org/10.3758/s13421-019-00896-7
   PubMed Web of Science ®Google Scholar
• McDade, E., Wang, G., Gordon, B. A., Hassenstab, J., Benzinger, T. L. S., Buckles, V., Fagan, A. M., Holtzman, D. M., Cairns, N. J., Goate, A. M., Marcus, D. S., Morris, J. C., Paumier, K., Xiong, C., Allegri, R., Berman, S. B., Klunk, W., Noble, J., & Ringman, J. (2018). Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology, 91(14), e1295–e1306. Dominantly Inherited Alzheimer Network. https://doi.org/10.1212/WNL.0000000000006277
   PubMed Web of Science ®Google Scholar
• Mielke, M. M., Aakre, J. A., Algeciras-Schimnich, A., Proctor, N. K., Machulda, M. M., Eichenlaub, U., Knopman, D. S., Vemuri, P., Graff-Radford, J., Jack, C. R., Petersen, R. C., & Dage, J. L. (2022). Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline. Alzheimer’s & Dementia, 18(4), 602–611. https://doi.org/10.1002/alz.12415
   PubMed Web of Science ®Google Scholar
• Morris, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology, 39(9), 1159–1165. https://doi.org/10.1212/wnl.39.9.1159
   PubMed Web of Science ®Google Scholar
• Moser, B., Deisenhammer, E. A., Marksteiner, J., Papousek, I., Fink, A., & Weiss, E. M. (2014). Serial position effects in patients with mild cognitive impairment and early and moderate Alzheimer’s disease compared with healthy comparison subjects. Dementia and Geriatric Cognitive Disorders, 37(1–2), 19–26. https://doi.org/10.1159/000351675
   PubMed Web of Science ®Google Scholar
• Murdock, B. B., Jr. (1962). The serial position effect of free recall. Journal of Experimental Psychology, 64(5), 482–488. https://doi.org/10.1037/h0045106
   Google Scholar
• Nag, S., Yu, L., Boyle, P. A., Leurgans, S. E., Bennett, D. A., & Schneider, J. A. (2018). TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease. Acta Neuropathologica Communications, 6, 33. https://doi.org/10.1186/s40478-018-0531-3
   PubMed Web of Science ®Google Scholar
• Nag, S., Yu, L., Capuano, A. W., Wilson, R. S., Leurgans, S. E., Bennett, D. A., & Schneider, J. A. (2015). Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer’s disease. Annals of Neurology, 77, 942–952. https://doi.org/10.1002/ana.24388
   PubMed Web of Science ®Google Scholar
• Neddens, J., Temmel, M., Flunkert, S., Kerschbaumer, B., Hoeller, C., Loeffler, T., Niederkofler, V., Daum, G., Attems, J., & Hutter-Paier, B. (2018). Phosphorylation of different tau sites during progression of Alzheimer’s disease. Acta Neuropathologica Communications, 6(1), 52. https://doi.org/10.1186/s40478-018-0557-6
   PubMedGoogle Scholar
• Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Del Tredici, K., Duyckaerts, C., Frosch, M. P., Haroutunian, V., Hof, P. R., Hulette, C. R., Hyman, B. T., Iwatsubo, T., Jellinger, K. A., Jicha, G. A., & Beach, T. G. (2012). Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. Journal of Neuropathology and Experimental Neurology, 71(5), 362–381. https://doi.org/10.1097/NEN.0b013e31825018f7
   PubMed Web of Science ®Google Scholar
• O’Shea, D. M., Thomas, K. R., Asken, B., Lee, A. K. W., Davis, J. D., Malloy, P. F., Salloway, S. P., & Correia, S. (2021). Adding cognition to AT(N) models improves prediction of cognitive and functional decline. Alzheimer’s & Dementia, 13(1), e12174. https://doi.org/10.1002/dad2.12174
   Web of Science ®Google Scholar
• Palmqvist, S., Tideman, P., Cullen, N., Zetterberg, H., Blennow, K., Alzheimer’s Disease, N. I., Dage, J. L., Stomrud, E., Janelidze, S., Mattsson-Carlgren, N., & Hansson, O. (2021). Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures. Nature Medicine, 27(6), 1034–1042. https://doi.org/10.1038/s41591-021-01348-z
   PubMed Web of Science ®Google Scholar
• Pichet Binette, A., Palmqvist, S., Bali, D., Farrar, G., Buckley, C. J., Wolk, D. A., Zetterberg, H., Blennow, K., Janelidze, S., & Hansson, O. (2022). Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients. Alzheimer’s Research & Therapy, 14(1), 46. https://doi.org/10.1186/s13195-022-00990-0
   PubMed Web of Science ®Google Scholar
• Shen, X.-N., Huang, -Y.-Y., Chen, S.-D., Guo, Y., Tan, L., Dong, Q., & Yu, J.-T. (2021). Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status. Translational Psychiatry, 11(1), Article 1. https://doi.org/10.1038/s41398-021-01709-9
   Web of Science ®Google Scholar
• Sperling, R., Mormino, E., & Johnson, K. (2014). The evolution of preclinical Alzheimer’s disease: Implications for prevention trials. Neuron, 84(3), 608–622. https://doi.org/10.1016/j.neuron.2014.10.038
   PubMed Web of Science ®Google Scholar
• Talamonti, D., Koscik, R., Johnson, S., & Bruno, D. (2019). Predicting early mild cognitive impairment with free recall: The primacy of primacy. Archives of Clinical Neuropsychology, 35(2), 133–142. https://doi.org/10.1093/arclin/acz013
   Web of Science ®Google Scholar
• Talmi, D., Grady, C. L., Goshen-Gottstein, Y., & Moscovitch, M. (2005). Neuroimaging the serial position curve. A test of single-store versus dual-store models. Psychological Science, 16(9), 716–723. https://doi.org/10.1111/j.1467-9280.2005.01601.x
   PubMed Web of Science ®Google Scholar
• Thomas, K. R., Bangen, K. J., Edmonds, E. C., Weigand, A. J., Walker, K. S., Bondi, M. W., & Galasko, D. R. (2021). Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer’s disease‐related declines. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 13(1), e12238. https://doi.org/10.1002/dad2.12238
   PubMedGoogle Scholar
• Thomas, K. R., Bangen, K. J., Weigand, A. J., Edmonds, E. C., Wong, C. G., Cooper, S., Delano-Wood, L., & Bondi, M. W., & Alzheimer’s Disease Neuroimaging Initiative. (2020). Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology, 94 (4), e397–e406. https://doi.org/10.1212/WNL.0000000000008838
   PubMed Web of Science ®Google Scholar
• Thomas, K. R., Edmonds, E. C., Eppig, J., Salmon, D. P., & Bondi, M. W., & Alzheimer’s Disease Neuroimaging Initiative. (2018). Using neuropsychological process scores to identify subtle cognitive decline and predict progression to mild cognitive impairment. Journal of Alzheimer’s Disease, 64 (1), 195–204. https://doi.org/10.3233/JAD-180229
   PubMed Web of Science ®Google Scholar
• Thomas, K. R., Weigand, A. J., Edwards, L. C., Edmonds, E. C., Bangen, K. J., Ortiz, G., Walker, K. S., & Bondi, M. W., & Alzheimer’s Disease Neuroimaging Initiative. (2022). Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint. Alzheimer’s Research & Therapy, 14 (1), 114. https://doi.org/10.1186/s13195-022-01060-1
   PubMed Web of Science ®Google Scholar
• Trelle, A. N., Carr, V. A., Wilson, E. N., Swarovski, M. S., Hunt, M. P., Toueg, T. N., Tran, T. T., Channappa, D., Corso, N. K., Thieu, M. K., Jayakumar, M., Nadiadwala, A., Guo, W., Tanner, N. J., Bernstein, J. D., Litovsky, C. P., Guerin, S. A., Khazenzon, A. M., Harrison, M. B., & Mormino, E. C. (2021). Association of CSF biomarkers with hippocampal-dependent memory in preclinical Alzheimer disease. Neurology, 96(10), e1470–e1481. https://doi.org/10.1212/WNL.0000000000011477
   PubMed Web of Science ®Google Scholar
• Weitzner, D. S., & Calamia, M. (2020). Serial position effects on list learning tasks in mild cognitive impairment and Alzheimer’s disease. Neuropsychology, 34(4), 467–478. https://doi.org/10.1037/neu0000620
   PubMed Web of Science ®Google Scholar
• Wennström, M., Janelidze, S., Nilsson, K. P. R., The Netherlands Brain Bank, S., Beach, G. E., Dage, J. L., & Hansson, O. (2022). Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels. Acta Neuropathologica Communications, 10(3), 1–12. https://doi.org/10.1186/s40478-021-01305-4
   PubMedGoogle Scholar
• Wilson, R. S., Yang, J., Yu, L., Leurgans, S. E., Capuano, A. W., Schneider, J. A., Bennett, D. A., & Boyle, P. A. (2019). Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology, 92(8), e831–e840. https://doi.org/10.1212/WNL.0000000000006949
   PubMed Web of Science ®Google Scholar
• Yu, L., Petyuk, V. A., Gaiteri, C., Mostafavi, S., Young-Pearse, T., Shah, R. C., Buchman, A. S., Schneider, J. A., Piehowski, P. D., Sontag, R. L., Fillmore, T. L., Shi, T., Smith, R. D., De Jager, P. L., & Bennett, D. A. (2018). Targeted brain proteomics uncover multiple pathways to Alzheimer’s dementia. Annals of Neurology, 84(1), 78–88. https://doi.org/10.1002/ana.25266
   PubMed Web of Science ®Google Scholar